Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A placebo‐controlled investigation of the analgesic effects, abuse liability, safety and tolerability of a range of oral cannabidiol doses in healthy humans
Caroline A. Arout, Margaret Haney, Evan S. Herrmann, et al.
British Journal of Clinical Pharmacology (2021) Vol. 88, Iss. 1, pp. 347-355
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Peripheral Voltage-Gated Cation Channels in Neuropathic Pain and Their Potential as Therapeutic Targets
Sascha R.A. Alles, Peter A. Smith
Frontiers in Pain Research (2021) Vol. 2
Open Access | Times Cited: 56
The safety and efficacy of low oral doses of cannabidiol: An evaluation of the evidence
Jonathon C. Arnold, Danielle McCartney, Anastasia Suraev, et al.
Clinical and Translational Science (2022) Vol. 16, Iss. 1, pp. 10-30
Open Access | Times Cited: 54
Statement on safety of cannabidiol as a novel food: data gaps and uncertainties
Dominique Turck, Torsten Bohn, Jacqueline Castenmiller, et al.
EFSA Journal (2022) Vol. 20, Iss. 6
Open Access | Times Cited: 49
The therapeutic potential of purified cannabidiol
Saoirse E. O’Sullivan, Sanne Jensen, Gitte Nykjaer Nikolajsen, et al.
Journal of Cannabis Research (2023) Vol. 5, Iss. 1
Open Access | Times Cited: 29
Therapeutic potential of cannabidiol polypharmacology in neuropsychiatric disorders
Olivier J. Manzoni, Antonia Manduca, Viviana Trezza
Trends in Pharmacological Sciences (2025)
Open Access | Times Cited: 1
Neuroprotective potential of cannabidiol: Molecular mechanisms and clinical implications
Srushti Tambe, Suraj N. Mali, Purnima Amin, et al.
Journal of Integrative Medicine (2023) Vol. 21, Iss. 3, pp. 236-244
Closed Access | Times Cited: 17
Does acute cannabidiol (CBD) use impair performance? A meta-analysis and comparison with placebo and delta-9-tetrahydrocannabinol (THC)
Lindsay A. Lo, April Christiansen, Justin C. Strickland, et al.
Neuropsychopharmacology (2024) Vol. 49, Iss. 9, pp. 1425-1436
Open Access | Times Cited: 7
CBD supplementation reduces arterial blood pressure via modulation of the sympatho-chromaffin system: A substudy from the HYPER-H21-4 trial
Marko Kumrić, Goran Dujić, Josip Vrdoljak, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114387-114387
Open Access | Times Cited: 14
Update on Cannabidiol Clinical Toxicity and Adverse Effects: A Systematic Review
Graziella Madeo, Ashita Kapoor, Raffaele Giorgetti, et al.
Current Neuropharmacology (2023) Vol. 21, Iss. 11, pp. 2323-2342
Open Access | Times Cited: 14
Cannabinoids and endocannabinoids as therapeutics for nervous system disorders: preclinical models and clinical studies
R. Scott Duncan, Sean M. Riordan, Matthew C. Gernon, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 4, pp. 788-799
Open Access | Times Cited: 14
Biphasic effects of cannabis and cannabinoid therapy on pain severity, anxiety, and sleep disturbance: a scoping review
Alexander Shustorovich, Jamie Corroon, Mark S. Wallace, et al.
Pain Medicine (2024) Vol. 25, Iss. 6, pp. 387-399
Closed Access | Times Cited: 5
Cannabinoids for Acute Pain Management: Approaches and Rationale
Mihai Botea, Lukas Andereggen, Richard D. Urman, et al.
Current Pain and Headache Reports (2024) Vol. 28, Iss. 7, pp. 681-689
Open Access | Times Cited: 5
Novel Drug Targets and Emerging Pharmacotherapies in Neuropathic Pain
Jurga Bernatonienė, Arūnas Ščiupokas, Dalia M. Kopustinskienė, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1799-1799
Open Access | Times Cited: 12
Cannabidiol (CBD) Products for Pain: Ineffective, Expensive, and With Potential Harms
Andrew Moore, Sebastian Straube, Emma Fisher, et al.
Journal of Pain (2023) Vol. 25, Iss. 4, pp. 833-842
Open Access | Times Cited: 11
Therapeutic Polymer-Based Cannabidiol Formulation: Tackling Neuroinflammation Associated with Ischemic Events in the Brain
Merari Tumin Chevalier, Mansoor Al-Waeel, Amir M. Alsharabasy, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 4, pp. 1609-1624
Open Access | Times Cited: 4
Cannabis Use in Adults with Neuropathic versus Non-Neuropathic Pain
Carl Joshua Laroya, Crystal Lederhos Smith, Ross Bindler, et al.
Research Square (Research Square) (2025)
Closed Access
An Overview of Cannabidiol
Alexandra Sideris, Lisa Doan
Anesthesia & Analgesia (2023) Vol. 138, Iss. 1, pp. 54-68
Open Access | Times Cited: 9
Neuroimaging studies of cannabidiol and potential neurobiological mechanisms relevant for alcohol use disorders: a systematic review
Tristan Hurzeler, Joshua Watt, Warren Logge, et al.
Journal of Cannabis Research (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 3
The Development of Cannabinoids as Therapeutic Agents in the United States
Conor H. Murray, Brenda M. Gannon, Peter J. Winsauer, et al.
Pharmacological Reviews (2024) Vol. 76, Iss. 5, pp. 915-955
Open Access | Times Cited: 3
Effects of rich cannabidiol oil on behavioral disturbances in patients with dementia: A placebo controlled randomized clinical trial
Vered Hermush, Liora Ore, Noa Stern, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 13
Cannabidiol and Beta-Caryophyllene in Combination: A Therapeutic Functional Interaction
Henry Blanton, Linda X. Yin, Joshua Duong, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15470-15470
Open Access | Times Cited: 13
Vaporized cannabis extract–induced antinociception in male vs female rats with persistent inflammatory pain
Rebecca M. Craft, Hannah Y. Gogulski, Timothy G. Freels, et al.
Pain (2023) Vol. 164, Iss. 9, pp. 2036-2047
Open Access | Times Cited: 7
Long-Term, Self-Dosing CBD Users: Indications, Dosage, and Self-Perceptions on General Health/Symptoms and Drug Use
Robert C. Kaufmann, Amber L. Harris Bozer, Amanda Kube, et al.
Medical Cannabis and Cannabinoids (2023) Vol. 6, Iss. 1, pp. 77-88
Open Access | Times Cited: 7
Preclinical Assessment of the Abuse Potential of Purified Botanical Cannabidiol: Self-Administration, Drug Discrimination, and Physical Dependence
Richard A. Gray, David J. Heal, David R. Maguire, et al.
Journal of Pharmacology and Experimental Therapeutics (2022) Vol. 382, Iss. 1, pp. 54-65
Open Access | Times Cited: 12
Role of Cannabidiol for Improvement of the Quality of Life in Cancer Patients: Potential and Challenges
Ryan Green, Roukiah Khalil, Shyam S. Mohapatra, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 12956-12956
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top